Sanofi prepares to price dollar fixed-rate notes in two tranches

By Cristal Cody

Tupelo, Miss., June 12 – Sanofi SA plans to price a dollar-denominated two-part offering of fixed-rate notes, according to a 424B5 filing with the Securities and Exchange Commission on Tuesday.

Barclays and Morgan Stanley & Co. LLC are the global coordinators and joint bookrunners. Other bookrunners are Citigroup Global Markets Inc., Deutsche Bank Securities Inc. and MUFG.

The notes will have make-whole and par calls.

Proceeds will be used for general corporate purposes, including to repay existing debt.

Sanofi is a Paris-based pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.